Thomsen T

References (7)

Title : The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6 - Bachus_1999_Pharmacogenet_9_661
Author(s) : Bachus R , Bickel U , Thomsen T , Roots I , Kewitz H
Ref : Pharmacogenetics , 9 :661 , 1999
PubMedID: 10634129

Title : In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers -
Author(s) : Thomsen T , Zendeh B , Fischer JP , Kewitz H
Ref : Biochemical Pharmacology , 41 :139 , 1991
PubMedID: 1986738

Title : Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine - Thomsen_1991_Eur.J.Clin.Chem.Clin.Biochem_29_487
Author(s) : Thomsen T , Kaden B , Fischer JP , Bickel U , Barz H , Gusztony G , Cervos-Navarro J , Kewitz H
Ref : European Journal of Clinical Chemistry & Clinical Biochemistry , 29 :487 , 1991
PubMedID: 1954303

Title : Acute poisoning with bromofosmethyl (bromophos) - Koppel_1991_J.Toxicol.Clin.Toxicol_29_203
Author(s) : Koppel C , Thomsen T , Heinemeyer G , Roots I
Ref : Journal of Toxicology Clinical Toxicology , 29 :203 , 1991
PubMedID: 2051507

Title : Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo - Thomsen_1990_Life.Sci_46_1553
Author(s) : Thomsen T , Kewitz H
Ref : Life Sciences , 46 :1553 , 1990
PubMedID: 2355800

Title : A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors - Thomsen_1989_Enzyme_42_219
Author(s) : Thomsen T , Kewitz H , Pleul O
Ref : Enzyme , 42 :219 , 1989
PubMedID: 2698348

Title : Estimation of cholinesterase activity (EC 3.1.1.7\; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors - Thomsen_1988_J.Clin.Chem.Clin.Biochem_26_469
Author(s) : Thomsen T , Kewitz H , Pleul O
Ref : J Clinical Chemistry Clinical Biochemistry , 26 :469 , 1988
PubMedID: 3065439